SCHEMBL7654878

SCHEMBL7654878

OCC(O)C(O)CNCc1ccc(CNCC(O)C(O)CO)nc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CXCR4 P61073 1/20 0.41
▸ PNP P00491 3/20 0.39
▸ KDM4E B2RXH2 1/20 0.37
▸ LMNA P02545 2/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ CD274 Q9NZQ7 2/20 0.35
▸ PDCD1 Q15116 1/20 0.35
▸ ADRB2 P07550 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ DNM1 Q05193 1/20 0.32
▸ BCHE P06276 1/20 0.32
▸ ANPEP P15144 1/20 0.32
▸ ERAP2 Q6P179 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ OPRM1 P35372 1/20 0.31
▸ OPRK1 P41145 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7657692 0.86 CD274 (0.46) CXCR4PNPKDM4ELMNAMEN1
SCHEMBL7662068 0.84 CXCR4 (0.43) CXCR4PNPKDM4ELMNAMEN1
SCHEMBL7105047 0.83 PNP (0.43) PNPKDM4EDNM1
SCHEMBL7652028 0.75 PNP (0.39) CXCR4PNPCD274PDCD1
SCHEMBL7662084 0.75 CXCR4 (0.52) CXCR4LMNAMEN1KMT2ACD274
SCHEMBL7108663 0.73 PNP (0.39) PNPKDM4E
SCHEMBL7655578 0.73 PNP (0.39) PNPADRB2ALDH1A1CYP1A2CYP2D6
SCHEMBL7650049 0.73 TRPV3 (0.43) CXCR4PNPKDM4EDNM1SMN1; SMN2
SCHEMBL7663658 0.70 CXCR4 (0.35) CXCR4PNPCD274PDCD1ADRB2
SCHEMBL11670929 0.69 KDM4E (0.61) PNPKDM4EALDH1A1CYP1A2DNM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6399613-B1 N,N'-BIS(2-HYDROXYETHYL)PYRAZINE-2,5- OR -2,6-DICARBOXAMIDE; DIABETES AVENTIS PHARMA S.A. (FR) 2002-06-04 — — US claimed
US-6399613-B1 N,N'-BIS(2-HYDROXYETHYL)PYRAZINE-2,5- OR -2,6-DICARBOXAMIDE; DIABETES AVENTIS PHARMA S.A. (FR) 2002-06-04 — — US disclosed
Send feedback